Recovering scientist turned early stage VC A biotech optimist fighting gravity

The Record-Breaking Biotech Funding Tsunami Of 1H2020
July 15, 2020

We’re half way through one of the craziest years in recent memory, with a raging viral pandemic, civil unrest and protests, staggering unemployment and economic woes, and invasive murder hornets. And yet, like the indefatigable Energizer bunny, the biotech market

Leave a comment

Grit At A Grand Scale: Cultivating Resilience At The Organizational Level
July 8, 2020

By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC. “Hey, you know, breakdowns come. And breakdowns go. So what are you going to do about it? That’s what I’d like to know – Gumboots In an

Leave a comment

Nurturing A Culture Of “Smart Speed” To Bring Gene Therapy To The World
June 23, 2020

By Deanna Petersen, chief business officer at AVROBIO, and Georgette Verdin, chief human resources officer at AVROBIO, as part of the From The Trenches feature of LifeSciVC. As we approach our 5th anniversary and surpass our 125th hire, we have

Leave a comment

Leading and Learning Through Challenging World Events
June 18, 2020

By Jodie Morrison, CEO of Cadent Therapeutics, as part of the From The Trenches feature of LifeSciVC It’s been over three months since stay at home advisories and social distancing protocols abruptly arrived in Massachusetts. Calls for a return to

Leave a comment

Will Clinical Trials Make a House Call?
June 15, 2020

By Aoife Brennan, CEO of Synlogic, as part of the From The Trenches feature of LifeSciVC I love to travel. While still in training in internal medicine, I earned extra money to fund trips abroad by covering for community-based general

Leave a comment

Controlling Your Destiny: Why Investment in Manufacturing Capabilities Makes Sense
May 28, 2020

By Philip Astley-Sparke, CEO of Replimune, as part of the From The Trenches feature of LifeSciVC. Manufacturing of medicines based on biology is complex. Viral vector manufacturing to produce gene therapy constructs, vaccines and oncolytic viruses is especially intricate. Most

Leave a comment

The Business Of Science
May 21, 2020

This blog was written by Jonathan Montagu, CEO and co-founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC. Today marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it

Leave a comment

Long-Range Planning (LRP): Reframed Leaders Require Purpose
May 8, 2020

This blog was written by Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC. In an environment where senior leaders are tasked with defining agile strategies in uncertain times, there are many perspectives

Leave a comment

Ordinary People Achieving The Extraordinary: Lessons In Leadership From The Court To The C-suite
April 30, 2020

This blog was written by Josh Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC. I stood in front of 15 skeptical parents and prepared to sell them on an improbable mission. They had

Leave a comment

Running Rehab: Managing Talent In A Pandemic
April 27, 2020

This blog was written by Andrea DiMella, VP and Head of Talent at Atlas Venture, as part of the From The Trenches feature of LifeSciVC. What a difference a little time makes. When Bruce originally encouraged me to be a

Leave a comment

Reflections of an Immigrant CEO 
April 23, 2020

This blog post was written by Gerhard Koenig, CEO of Arkuda Therapeutics, as part of the From The Trenches feature of LifeSciVC. When I discussed the topic of writing about my experience as an immigrant biotech CEO with Bruce Booth,

Leave a comment

Value Creation And Destruction: Dispersion of Performance In Biotech IPOs
April 17, 2020

The biotech IPO market in 2020 remains strong, despite the volatility and COVID headwinds. We’ve seen stellar pricings and good after-market performance, with ten new offerings already this year. And the queue for companies with active S1’s on file is

Leave a comment